1235.6000 18.10 (1.49%)
NSE Jan 23, 2026 15:31 PM
Volume: 3.9M
High volume today

ICICI Direct
About the stock: Dr Reddy's (DRL) business encompasses generic formulations sales across US, Europe, RoW markets and branded generics in India and Russia CIS. The business also comprises of API sales under the head PSAI. The company...
Number of FII/FPI investors decreased from 872 to 855 in Dec 2025 qtr
More from Dr. Reddy's Laboratories Ltd.
Recommended